TD Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-13,583
| Closed | -$74K | – | 1383 |
|
|
2019
Q4 | $74K | Sell |
13,583
-29,995
| -69% | -$163K | ﹤0.01% | 1384 |
|
|
2019
Q3 | $131K | Sell |
43,578
-6,000
| -12% | -$18K | ﹤0.01% | 1318 |
|
|
2019
Q2 | $185K | Buy |
49,578
+2,200
| +5% | +$8.21K | ﹤0.01% | 1301 |
|
|
2019
Q1 | $190K | Buy |
47,378
+300
| +0.6% | +$1.2K | ﹤0.01% | 1311 |
|
|
2018
Q4 | $173K | Buy |
47,078
+600
| +1% | +$2.21K | ﹤0.01% | 1358 |
|
|
2018
Q3 | $399K | Buy |
46,478
+1,800
| +4% | +$15.5K | ﹤0.01% | 1336 |
|
|
2018
Q2 | $491K | Buy |
44,678
+400
| +0.9% | +$4.4K | ﹤0.01% | 1268 |
|
|
2018
Q1 | $511K | Buy |
+44,278
| New | +$511K | ﹤0.01% | 1195 |
|
|
2017
Q3 | – | Sell |
-10,744
| Closed | -$130K | – | 1306 |
|
|
2017
Q2 | $130K | Sell |
10,744
-13,305
| -55% | -$161K | ﹤0.01% | 1323 |
|
|
2017
Q1 | $499K | Buy |
24,049
+1,805
| +8% | +$37.5K | ﹤0.01% | 1215 |
|
|
2016
Q4 | $318K | Sell |
22,244
-1,300
| -6% | -$18.6K | ﹤0.01% | 1286 |
|
|
2016
Q3 | $387K | Buy |
+23,544
| New | +$387K | ﹤0.01% | 1247 |
|